European Companies Search Engine

Managing Director (2) · Change of headquarters: i3 Pharmaceutical Services (Deutschland) GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy · Corporate Purpose Hrb17 Jun 2013 German Trade Register Announcement, Germany (12/06/2013)

Overview

Text

i3 Pharmaceutical Services (Deutschland) GmbH, Neu-Isenburg, Frankfurter Straße 233, Ungenannte Str. ??, 63263 Neu-Isenburg, Germany. GmbH. Partnership agreement of May 12, 2000, amended several times. The shareholders meeting of April 11, 2013 decided to amend the partnership agreement in Section 2 (seat) and with it the transfer of its registered office from Wiesbaden (previously District Court of Wiesbaden HRB 21963) to Neu-Isenburg. Business address: Frankfurter Straße 233, Ungenannte Str. ??, 63263 Neu-Isenburg, Germany. The aim is to (i) provide counselling and other services in the field of clinical research. This includes in particular data management, drug monitoring, health economics and results research services, project management and other administrative services; the organisation of test centres to conduct clinical trials on authorised and investigative medicines, import, packaging, dispatch, labelling and distribution of medicines; collecting laboratory samples from clinical trial sites; monitoring, recruiting and training of clinical research staff; the schools of clinical trial staff with regard to the conditions for drug control and the use of test and evaluation systems, including the provision of the appropriate materials; the review of potential clinical testing centres and the submission of all regulatory-required applications for new research projects (ii) the recruitment and provision of staff to pharmaceutical and medical device companies and (iii) the provision of advisory and other support services and related assistance to physicians, hospitals, employers, insurers, health insurance funds and other healthcare institutions or organisations. Share capital: EUR 25,000.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Managing Directors: ??????????, ????? ??????, Manchester, Michigan/USA, *??.??.????; Sherbet, Eric Mitchell, Newton/USA, *??.??.????, each with individual representatives; with the power to enter into legal transactions on behalf of the company in its own name or a.s. a representative of a third party.

This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Syneos Health Germany GmbH, Munich, Germany.

Creative Commons License The visualizations for "i3 Pharmaceutical Services (Deutschland) GmbH - Managing Director (2) · Change of headquarters: i3 Pharmaceutical Services (Deutschland) GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy · Corporate Purpose" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.